Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RETA | LQDA | COGT | ||
| Company | Reata Pharma | Liquidia Corp | Cogent Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 172.34 | 76.54 | 37.90 | ||
| High | 172.46 | 79.40 | 38.16 | ||
| Low | 172.32 | 76.51 | 37.01 | ||
| Latest | 172.36 | 78.17 | 38.10 | ||
| Change | +0.04 | +1.25 | +0.09 | ||
| % Change | +0.02% | +1.63% | +0.24% | ||
| Volume | 1,988,500 | 3,549,879 | 9,013,107 | ||
| 20-Day Average Volume | 810,510 | 2,749,284 | 3,098,330 | ||
| Previous Close | 172.32 | 76.92 | 38.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 170.84 | 67.57 | 33.95 | ||
| 20-Day Raw Stochastic | 97.36% | 95.31% | 80.70% | ||
| 20-Day Relative Strength | 81.56 | 73.37 | 63.82 | ||
| Weighted Alpha | +177.60 | +365.52 | +104.21 | ||
| Today's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.18% since 09/18/23 | +9.99% since 06/18/26 | +10.31% since 06/18/26 | ||
| Low | 171.96 on 09/19/23 | 71.77 on 06/22/26 | 34.70 on 06/23/26 | ||
| High | 172.46 on 09/25/23 | 79.40 on 06/26/26 | 39.81 on 06/25/26 | ||
| 1-Month | |||||
| %Chg | +1.99% since 08/25/23 | +30.08% since 05/26/26 | +12.26% since 05/26/26 | ||
| Low | 168.67 on 09/05/23 | 53.06 on 06/03/26 | 30.93 on 06/10/26 | ||
| High | 172.46 on 09/25/23 | 79.40 on 06/26/26 | 39.81 on 06/25/26 | ||
| 3-Month | |||||
| %Chg | +83.77% since 06/23/23 | +112.59% since 03/26/26 | +3.34% since 03/26/26 | ||
| Low | 88.80 on 06/27/23 | 34.78 on 03/30/26 | 30.87 on 05/19/26 | ||
| High | 172.46 on 09/25/23 | 79.40 on 06/26/26 | 39.81 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +101.14% since 03/24/23 | +127.17% since 12/26/25 | -2.01% since 12/26/25 | ||
| Low | 76.54 on 05/10/23 | 29.12 on 02/26/26 | 30.87 on 05/19/26 | ||
| High | 172.46 on 09/25/23 | 79.40 on 06/26/26 | 41.35 on 01/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,575,535 | 6,840,342 | 6,494,693 | ||
| Shares Outstanding, K | 38,150 | 88,928 | 170,868 | ||
| Annual Sales | 2,220,000 | 158,320,000 | 0 | ||
| Annual Net Income | -311,900,000 | -68,920,000 | -328,940,000 | ||
| Last Quarter Sales | 22,750,000 | 132,870,000 | 0 | ||
| Last Quarter Net Income | 193,000,000 | 52,860,000 | -97,350,000 | ||
| 60-Month Beta | 1.42 | 0.58 | 0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.32 on 08/08/23 | 0.52 on 05/11/26 | -0.53 on 05/05/26 | ||
| Earnings Date | 11/14/23 | 08/11/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 539.57 | 0.00 | ||